RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISION
The article provides an analysis of using medications in children’s oncohematological department in Tomsk in 2008. Over that period 52 children aged from 6 months to 18 years were treated (with an acute lymphatic leukaemia, lymphogranulomatosis, non Hodgkin lymphom, acute and chronic myeloblastic le...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2010-05-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/1137 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849695667308462080 |
|---|---|
| author | Z.A. Maevskaya R.N. Luchinina I.E. Gerbek Yu.P. Chasovskikh I.Yu. Smirnova О.М. Fal'kovich |
| author_facet | Z.A. Maevskaya R.N. Luchinina I.E. Gerbek Yu.P. Chasovskikh I.Yu. Smirnova О.М. Fal'kovich |
| author_sort | Z.A. Maevskaya |
| collection | DOAJ |
| description | The article provides an analysis of using medications in children’s oncohematological department in Tomsk in 2008. Over that period 52 children aged from 6 months to 18 years were treated (with an acute lymphatic leukaemia, lymphogranulomatosis, non Hodgkin lymphom, acute and chronic myeloblastic leukemia, etc.). According to АВС/VEN analysis, 79,9% of funds was spent on acquisition of 11 group A medications, 15,1% — on group B medications, 5% — on group C medications. Vital medications (V) accounted for 79,4%, essential medications (Е) — 14,7%, non-essential medications (N) — 5,9%. The authors examined the toxicity of vincristine depending on manufacturers. Key words: children, malignant blood diseases, ABC/VEN analysis, vincristine, neurotoxicity. (Pediatric Pharmacology. – 2010; 7(3):14-16) |
| format | Article |
| id | doaj-art-e48646848bf9482a936ba5407406cb15 |
| institution | DOAJ |
| issn | 1727-5776 2500-3089 |
| language | Russian |
| publishDate | 2010-05-01 |
| publisher | Union of pediatricians of Russia |
| record_format | Article |
| series | Педиатрическая фармакология |
| spelling | doaj-art-e48646848bf9482a936ba5407406cb152025-08-20T03:19:42ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892010-05-017314161132RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISIONZ.A. Maevskaya0R.N. Luchinina1I.E. Gerbek2Yu.P. Chasovskikh3I.Yu. Smirnova4О.М. Fal'kovich5Sibirsky State Medical University, TomskSibirsky State Medical University, TomskSibirsky State Medical University, TomskSibirsky State Medical University, TomskTomsk Regional Clinical HospitalTomsk Regional Clinical HospitalThe article provides an analysis of using medications in children’s oncohematological department in Tomsk in 2008. Over that period 52 children aged from 6 months to 18 years were treated (with an acute lymphatic leukaemia, lymphogranulomatosis, non Hodgkin lymphom, acute and chronic myeloblastic leukemia, etc.). According to АВС/VEN analysis, 79,9% of funds was spent on acquisition of 11 group A medications, 15,1% — on group B medications, 5% — on group C medications. Vital medications (V) accounted for 79,4%, essential medications (Е) — 14,7%, non-essential medications (N) — 5,9%. The authors examined the toxicity of vincristine depending on manufacturers. Key words: children, malignant blood diseases, ABC/VEN analysis, vincristine, neurotoxicity. (Pediatric Pharmacology. – 2010; 7(3):14-16)https://www.pedpharma.ru/jour/article/view/1137 |
| spellingShingle | Z.A. Maevskaya R.N. Luchinina I.E. Gerbek Yu.P. Chasovskikh I.Yu. Smirnova О.М. Fal'kovich RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISION Педиатрическая фармакология |
| title | RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISION |
| title_full | RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISION |
| title_fullStr | RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISION |
| title_full_unstemmed | RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISION |
| title_short | RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISION |
| title_sort | rational pharmaceutical management in practice of children s oncohematological division |
| url | https://www.pedpharma.ru/jour/article/view/1137 |
| work_keys_str_mv | AT zamaevskaya rationalpharmaceuticalmanagementinpracticeofchildrensoncohematologicaldivision AT rnluchinina rationalpharmaceuticalmanagementinpracticeofchildrensoncohematologicaldivision AT iegerbek rationalpharmaceuticalmanagementinpracticeofchildrensoncohematologicaldivision AT yupchasovskikh rationalpharmaceuticalmanagementinpracticeofchildrensoncohematologicaldivision AT iyusmirnova rationalpharmaceuticalmanagementinpracticeofchildrensoncohematologicaldivision AT omfalkovich rationalpharmaceuticalmanagementinpracticeofchildrensoncohematologicaldivision |